3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Failure
1
Hepatitis C
1
Hepatitis B
1
Hepatic Insufficiency
1
HIV Infections
1
Carcinoma, Hepatocellular
1
Interventions
Oxaliplatin
152
Fluorouracil
137
Gemcitabine
118
Bevacizumab
116
Leucovorin
106
Specimen Handling
105
Capecitabine
96
pembrolizumab
90
Magnetic Resonance Spectroscopy
83
Nivolumab
79
Cisplatin
79
Irinotecan
71
durvalumab
64
Cetuximab
62
Biopsy
61
Paclitaxel
60
130-nm albumin-bound paclitaxel
59
Radiotherapy
46
atezolizumab
45
Albumin-Bound Paclitaxel
37
Taxes
36
Carboplatin
36
Folfox protocol
35
Drug Therapy
32
Cyclophosphamide
30
lenvatinib
29
dehydroftorafur
29
tislelizumab
27
sintilimab
27
Radiation
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Raltegravir Potassium
×
Gastrointestinal
×
90 days
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled